Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VALUE AND VOLUME
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
6.1 INCIDENCE OF HEART FAILURE
6.2 INCIDENCE OF STROKE
6.3 INCIDENCE OF ARRHYTHMIAS
6.4 PREVALENCE OF ISCHEMIC HEART DISEASE
7 PREMIUM INSIGHTS
7.1 PESTEL ANALYSIS
7.2 PORTER’S 5 FORCES
7.3 VENDOR ASSESMENT
7.4 TECHNOLOGICAL ASSESSMENT
8 REGULATORY FRAMWORK
9 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, BY COMPONENT
9.1 OVERVIEW
9.2 SERVICES
9.2.1 BUSINESS CONTINUITY
9.2.2 INTEGRATION
9.2.3 VENDOR NEUTRALITY
9.2.4 INSTALLATION
9.2.5 MAINTAINANCE
9.2.6 OTHERS
9.3 SOFTWARE
9.3.1 ELECTRONIC MEDICAL RECORDS (EMR)
9.3.2 ELECTRONIC HEALTH RECORDS (EHR)
9.3.3 OTHERS
9.4 SYSTEMS
9.4.1 CARDIAC PACS
9.4.1.1. MARKET VALUE (USD MILLION)
9.4.1.2. MARKET VALUE (UNITS)
9.4.1.3. AVERAGE SELLING PRICE (USD)
9.4.2 ECHO VIEWER
9.4.2.1. MARKET VALUE (USD MILLION)
9.4.2.2. MARKET VALUE (UNITS)
9.4.2.3. AVERAGE SELLING PRICE (USD)
9.4.3 ZERO FOOT PRINT VIEWER (ZFP)
9.4.3.1. MARKET VALUE (USD MILLION)
9.4.3.2. MARKET VALUE (UNITS)
9.4.3.3. AVERAGE SELLING PRICE (USD)
9.4.4 HOSPITAL INFORMATION SYSTEM
9.4.4.1. MARKET VALUE (USD MILLION)
9.4.4.2. MARKET VALUE (UNITS)
9.4.4.3. AVERAGE SELLING PRICE (USD)
9.4.5 PATIENT REVIEW SYSTEM
9.4.5.1. MARKET VALUE (USD MILLION)
9.4.5.2. MARKET VALUE (UNITS)
9.4.5.3. AVERAGE SELLING PRICE (USD)
9.4.6 ELECTRONIC PATIENT DOSSIER (EPD)
9.4.6.1. MARKET VALUE (USD MILLION)
9.4.6.2. MARKET VALUE (UNITS)
9.4.6.3. AVERAGE SELLING PRICE (USD)
9.4.7 ANGIO-IMAGE STORAGE
9.4.7.1. MARKET VALUE (USD MILLION)
9.4.7.2. MARKET VALUE (UNITS)
9.4.7.3. AVERAGE SELLING PRICE (USD)
9.4.8 ANGIO-IMAGE VIEWER
9.4.8.1. MARKET VALUE (USD MILLION)
9.4.8.2. MARKET VALUE (UNITS)
9.4.8.3. AVERAGE SELLING PRICE (USD)
9.4.9 REGISTRATION AND ADMINISTRATION SYSTEM
9.4.9.1. MARKET VALUE (USD MILLION)
9.4.9.2. MARKET VALUE (UNITS)
9.4.9.3. AVERAGE SELLING PRICE (USD)
9.4.10 PATIENT MONITORING
9.4.10.1. MARKET VALUE (USD MILLION)
9.4.10.2. MARKET VALUE (UNITS)
9.4.10.3. AVERAGE SELLING PRICE (USD)
9.4.11 ECG MANAGEMENT SYSTEM
9.4.11.1. MARKET VALUE (USD MILLION)
9.4.11.2. MARKET VALUE (UNITS)
9.4.11.3. AVERAGE SELLING PRICE (USD)
9.4.12 OTHERS
10 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, BY TYPE
10.1 OVERVIEW
10.2 CARDIOVASCULAR INFORMATION SYSTEM (CVIS)
10.2.1 INTEGRATED
10.2.1.1. SYSTEMS
10.2.1.2. SOFTWARE
10.2.1.3. SERVICES
10.2.2 STANDALONE
10.2.2.1. SYSTEMS
10.2.2.2. SOFTWARE
10.2.2.3. SERVICES
10.3 CARDIOLOGY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (CPACS)
10.3.1 INTEGRATED
10.3.1.1. SYSTEMS
10.3.1.2. SOFTWARE
10.3.1.3. SERVICES
10.3.2 STANDALONE
10.3.2.1. SYSTEMS
10.3.2.2. SOFTWARE
10.3.2.3. SERVICES
10.4 OTHERS
11 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, BY MODE OF OPERATION
11.1 OVERVIEW
11.2 WEB-BASED
11.2.1 ECHO WORKFLOW
11.2.2 INTERVENTIONAL WORKFLOW
11.2.3 ECG WORKFLOW
11.2.4 CARDIAC CT/MR/NM WORKFLOW
11.2.5 CORONARY CARE
11.2.6 CLINICAL ELECTROPHYSIOLOGY
11.2.7 OTHERS
11.3 ON-PREMISE
11.3.1 ECHO WORKFLOW
11.3.2 INTERVENTIONAL WORKFLOW
11.3.3 ECG WORKFLOW
11.3.4 CARDIAC CT/MR/NM WORKFLOW
11.3.5 CORONARY CARE
11.3.6 CLINICAL ELECTROPHYSIOLOGY
11.3.7 OTHERS
12 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 L3A HOSPITALS
12.2.2 L3B AND L2 HOSPITALS
12.2.3 LEVEL 1 HOSPITALS
12.3 DIAGNOSTIC CENTERS
12.4 CLINICS
12.5 LABS
12.5.1 CATHETERIZATION LAB
12.5.2 PACEMAKER / ICD LAB
12.5.3 ECHOCARDIOGRAPHY LAB
12.5.4 ELECTROPHYSIOLOGY LAB
12.5.5 OTHERS
12.6 AMBULATORY SURGICAL CENTERS
12.7 CARDIAC REHABILITATION CENTERS
12.8 OTHERS
12.8.1
13 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, BY GEOGRAPHY
GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.1.1. U.S CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET BY COMPONENT
14.1.1.2. U.S CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET BY TYPE
14.1.1.3. U.S CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET BY MODE OF OPERATION
14.1.1.4. U.S CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET BY END USER
14.1.1.5. U.S CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET BY DISTRIBUTION CHANNEL
14.1.2 CANADA
14.1.3 MEXICO
14.2 EUROPE
14.2.1 GERMANY
14.2.2 FRANCE
14.2.3 U.K.
14.2.4 ITALY
14.2.5 SPAIN
14.2.6 RUSSIA
14.2.7 TURKEY
14.2.8 BELGIUM
14.2.9 NETHERLANDS
14.2.10 SWITZERLAND
14.2.11 REST OF EUROPE
14.3 ASIA-PACIFIC
14.3.1 JAPAN
14.3.2 CHINA
14.3.3 SOUTH KOREA
14.3.4 INDIA
14.3.5 AUSTRALIA
14.3.6 SINGAPORE
14.3.7 THAILAND
14.3.8 MALAYSIA
14.3.9 INDONESIA
14.3.10 PHILIPPINES
14.3.11 REST OF ASIA-PACIFIC
14.4 SOUTH AMERICA
14.4.1 BRAZIL
14.4.2 ARGENTINA
14.4.3 REST OF SOUTH AMERICA
14.5 MIDDLE EAST AND AFRICA
14.5.1 SOUTH AFRICA
14.5.2 SAUDI ARABIA
14.5.3 UAE
14.5.4 EGYPT
14.5.5 ISRAEL
14.5.6 REST OF MIDDLE EAST AND AFRICA
14.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
15 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, SWOT AND DBMR ANALYSIS
16 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: GLOBAL
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.3 COMPANY SHARE ANALYSIS: EUROPE
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16.5 MERGERS & ACQUISITIONS
16.6 NEW PRODUCT DEVELOPMENT & APPROVALS
16.7 EXPANSIONS
16.8 REGULATORY CHANGES
16.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
17 GLOBAL CARDIOLOGY INFORMATION SYSTEM (CIS) MARKET, COMPANY PROFILE
17.1 SOFTLINK INTERNATIONAL
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 GEOGRAPHIC PRESENCE
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 KONINKLIJKE PHILIPS N.V.
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 GEOGRAPHIC PRESENCE
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 CREALIFE SICHUANG GUANYU TECHNOLOGY
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 GEOGRAPHIC PRESENCE
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 CENTRAL DATA NETWORK
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 GEOGRAPHIC PRESENCE
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 INFINITT HEALTHCARE
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 GEOGRAPHIC PRESENCE
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 ESAOTE
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHIC PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 GENERAL ELECTRIC COMPANY
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 GEOGRAPHIC PRESENCE
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENTS
17.8 FUJIFILM HOLDINGS AMERICA CORPORATION
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHIC PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
17.9 SIEMENS MEDICAL SOLUTIONS USA, INC.
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 GEOGRAPHIC PRESENCE
17.9.4 PRODUCT PORTFOLIO
17.9.5 RECENT DEVELOPMENTS
17.1 ORACLE (CERNER)
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 GEOGRAPHIC PRESENCE
17.10.4 PRODUCT PORTFOLIO
17.10.5 RECENT DEVELOPMENTS
17.11 HEALTHY-IT, LLC
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 GEOGRAPHIC PRESENCE
17.11.4 PRODUCT PORTFOLIO
17.11.5 RECENT DEVELOPMENTS
17.12 CHANGE HEALTHCARE
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 GEOGRAPHIC PRESENCE
17.12.4 PRODUCT PORTFOLIO
17.12.5 RECENT DEVELOPMENTS
17.13 INTELERAD
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 GEOGRAPHIC PRESENCE
17.13.4 PRODUCT PORTFOLIO
17.13.5 RECENT DEVELOPMENTS
17.14 ABBOTT
17.14.1 COMPANY OVERVIEW
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHIC PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS
17.15 MCKESSON CORPORATION
17.15.1 COMPANY OVERVIEW
17.15.2 REVENUE ANALYSIS
17.15.3 GEOGRAPHIC PRESENCE
17.15.4 PRODUCT PORTFOLIO
17.15.5 RECENT DEVELOPMENTS
18 CONCLUSION
19 QUESTIONNAIRE
20 ABOUT DATA BRIDGE MARKET RESEARCH
